China Compliance Probes Slow Hospital Device Purchases, But Domestics Hit Harder Than MNCs
This article was originally published in PharmAsia News
Executive Summary
The medical device industry appears to have seen a different impact from China’s compliance investigations than the pharma industry, with domestic device companies faring worse than multinationals. China’s largest device maker Mindray reported sales significantly down while Stryker and Medtronic reported less impact.